NASDAQ$RXST
Rxsight Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Reported strong first quarter, driven by revenue growth and expanding installed base.
RxSight, Inc. reported a strong start to 2022 with a 157% increase in revenue compared to the first quarter of 2021, driven by increased sales of Light Delivery Devices and Light Adjustable Lenses. The company has revised its 2022 full year revenue guidance to a range of $41.5 million to $45.5 million.
- Delivered first quarter 2022 revenue of $8.9 million, a 157% increase compared to Q1 2021.
- Sold 40 Light Delivery Devices (LDD™s), a 208% unit increase from Q1 2021.
- Sold 4,166 Light Adjustable Lenses (LAL®s), a 166% increase in procedure volumes compared to Q1 2021.
- Revised 2022 revenue guidance to a range of $41.5 million to $45.5 million.
Headline financials
Revenue & EPS history
Rxsight · Revenue · Quarterly
$8.94M
Revenue by segment
Rxsight · $17.8M total across 2 segments · Q1 2022
- LAL Revenue$8.9M+155.5%50.0%
- LDD Revenue$8.9M+155.5%50.0%
Forward guidance
RxSight revised its 2022 full year revenue guidance to a range of $41.5 million to $45.5 million. The company did not change its guidance for 2022 gross margin or operating expenses, which are ranges of 35% to 36% of revenue, and $86.0 million to $90.0 million, respectively.
Tailwinds
- Revenue guidance increased to $41.5-$45.5 million.
- Implies an annual growth rate versus 2021 of 84% to 101%.
Headwinds
- Gross margin guidance remains at 35-36% of revenue.
- Operating expenses guidance remains at $86.0-$90.0 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2022
-1.1%
Avg return
Earnings day
-2.6%
Avg return
5 days after
+2.8%
Avg return
30 days after
45%
9 / 20 earnings
Positive
+15.1%
Q3 2022
Best reaction
-16.1%
Q2 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -6.6% | -21.6% | -31.1% | |
| Q4 2025 | -10.1% | -13.5% | -28.9% | |
| Q3 2025 | +8.7% | +16.3% | +46.7% | |
| Q1 2025 | -11.2% | -11.4% | +0.9% | |
| Q4 2024 | -0.8% | -7.8% | -9.1% | |
| Q3 2024 | -12.3% | -16.9% | -21.2% | |
| Q2 2024 | +14.6% | +21.5% | +29.0% | |
| Q1 2024 | +0.8% | -3.8% | -5.0% | |
| Q4 2023 | -5.8% | -3.2% | -10.9% | |
| Q3 2023 | +1.8% | +9.5% | +40.8% | |
| Q2 2023 | -1.5% | -6.3% | -1.8% | |
| Q1 2023 | +9.0% | +18.3% | +34.0% | |
| Q4 2022 | +9.7% | +4.5% | +17.9% | |
| Q3 2022 | +15.1% | +14.6% | +18.1% | |
| Q2 2022 | -2.9% | -8.3% | -13.3% | |
| Q1 2022 | -4.3% | -3.0% | +34.9% | |
| Q4 2021 | +1.4% | -3.2% | +1.8% | |
| Q3 2021 | +3.7% | -0.8% | -4.0% | |
| Q4 2020 | -16.1% | -18.4% | -21.1% | |
| Q2 2021 | -16.1% | -18.4% | -21.1% | |
| Q1 2021 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro